Join our daily newsletter At The Bell to receive exclusive market insights
IMEXHS (ASX:IME) has secured vital renewals for its enterprise software contracts, a revised agreement that has improved terms and pricing, contributing an expected $575,000 in annual recurring revenue over the next three years.
The first contract renewal is with Colsubsidio, a significant healthcare group in Colombia. The announcement was released post-market on Thursday.
Colsubsidio operates multiple radiology facilities, serving a large patient base across the region.
Additionally, IMEXHS also renewed and upgraded its contract with Clinica Medical, another client of similar ilk.
This renewal, spanning over two years, brings in Annualised Recurring Revenue of $425,000. The new agreement not only offers improved pricing but also expands the scope of services provided.
“We are very pleased with these two important renewals which show our strength in providing cutting edge medical imaging technology over many years,” Co-Founder and CEO of IMEXHS Dr. German Arango said.
These renewals underscore IMEXHS’s continued success in providing essential software solutions to healthcare organisations globally.
IMEXHS has been trading at 50 cents.
